<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This report describes a case of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_501'>myelomonocytic leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) in whom a complete remission was achieved and sustained 15 months after treatment with 25-OH <z:chebi fb="0" ids="28940">vitamin D3</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>No side-effects were observed </plain></SENT>
<SENT sid="2" pm="."><plain>Although vitamin D1 has been used in the treatment of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, to our knowledge this is the first case of long-standing remission in a patient with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>This 'differentiation therapy' might be considered as a possible alternative in the management of this disease </plain></SENT>
</text></document>